Comparison Overview
Roche CustomBiotech - North America
Roche CustomBiotech - North America
9115 Hague Rd, Indianapolis, 46256, US
Last Update: 23/03/2026
As part of Roche, CustomBiotech has been a leader in supplying innovative, high-quality products to forward-thinking biopharma and diagnostics businesses for more than 50 years. Our pioneering biopharma and diagnostic experts work together at one of Europe’s largest and...
Fortrea
Research Triangle Park, NC, US
Last Update: 02/04/2026
Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labco...
Compliance Ranges Comparison
Roche CustomBiotech - North America
Fortrea
Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Roche CustomBiotech - North America in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Fortrea in 2026.
Incident History - Roche CustomBiotech - North America (X = Date, Y = Severity)
Roche CustomBiotech - North America cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Fortrea (X = Date, Y = Severity)
Fortrea cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Roche CustomBiotech - North America
Fortrea
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.